When prescribed and monitored appropriately, retatrutide is considered safe for many patients
GLP-1-based therapies are legitimate prescription medications for approved medical conditions, and their use is protected health information under HIPAA regulations in the United States
10.1016/j.molmet.2024.101880 73 Outeirino-IglesiasV.Romani-PerezM.Gonzalez-MatiasL
2025 comprehensive formulary, Kaiser Permanente 2025 Medicare Part D comprehensive formulary, Kaiser Permanente Criteria-based consultation prescribing program (injectable semaglutide), Kaiser Permanente Northwest Region Novo Nordisk receives FDA approval of Ozempic (semaglutide) injection for the treatment of adults with Type 2 diabetes, PR Newswire (2017) Understanding drug tiers, Patient Advocate Foundation Drug formulary (covered drugs), Kaiser Permanente Find out if your insurance covers Ozempic, NovoCare Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Broadly, your options are 1) continue on the same dose of GLP-1 2) gradually lower your dose of GLP-1 to find the minimum effective dose that works for you 3) taper off your dose of GLP-1
